These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 224330

  • 1. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R, Gurtsevich V, Le Riverend E.
    Neoplasma; 1979; 26(2):125-31. PubMed ID: 224330
    [Abstract] [Full Text] [Related]

  • 2. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [Abstract] [Full Text] [Related]

  • 3. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba].
    Gurtsevich VE, Ruíz García R, Cuevas J, Le Riverand Morales E, Ascue M.
    Vopr Virusol; 1979 May; (4):392-9. PubMed ID: 225887
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].
    Mendoza J, Rojas A, de la Rosa M, Amador JM, Expósito J, Esquivias J.
    Med Clin (Barc); 1991 Nov 09; 97(16):609-11. PubMed ID: 1662737
    [Abstract] [Full Text] [Related]

  • 9. [Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl)].
    Wilmes E, Wolf H, Deinhardt F, Naumann HH.
    Laryngol Rhinol Otol (Stuttg); 1979 Dec 09; 58(12):911-5. PubMed ID: 231716
    [Abstract] [Full Text] [Related]

  • 10. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W, Cao SM, Huang QH, Li YH, Deng MQ.
    Ai Zheng; 2009 Jan 09; 28(1):57-9. PubMed ID: 19448418
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr 09; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM.
    J Clin Virol; 2008 Aug 09; 42(4):343-52. PubMed ID: 18455473
    [Abstract] [Full Text] [Related]

  • 14. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
    Ammatuna P, de Thè G, Speciale R, Sammartano F, Arista S, Zerillo G.
    Microbiologica; 1988 Apr 09; 11(2):89-94. PubMed ID: 2841559
    [Abstract] [Full Text] [Related]

  • 15. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov 09; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 16. Sero-epidemiologic study of the Epstein--Barr virus infectivity in a healthy Cuban population.
    Gurtsevich V, Le Riverend E, Ruíz R.
    Neoplasma; 1979 Nov 09; 26(6):677-83. PubMed ID: 232252
    [Abstract] [Full Text] [Related]

  • 17. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.
    Luo YL, Ou GP, Chi PD, Liang YN, Liu YH, Huang MY.
    Ai Zheng; 2009 Jan 09; 28(1):76-8. PubMed ID: 19448423
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX.
    Anticancer Res; 2001 Jan 09; 21(4B):3021-9. PubMed ID: 11712805
    [Abstract] [Full Text] [Related]

  • 19. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM, Mendoza Montero J, Expósito Hernández J, Salinero Hernández J, Esquivias López-Cuerpo J, Ballesteros García P.
    Acta Otorrinolaringol Esp; 1992 Jan 09; 43(1):31-6. PubMed ID: 1316136
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.